Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: KPV preclinical inflammation evidence
Also known as: Lys-Pro-Val
KPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), studied for anti-inflammatory activity primarily via NF-kB pathway inhibition, independent of classical melanocortin-receptor signaling in some models. It has strong preclinical evidence in colitis/gut-inflammation models and skin-barrier/wound research, and is notable for being transported across the intestinal epithelium intact, making oral delivery a research interest for GI inflammation applications.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary cell and mouse intestinal-inflammation studies
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
KPV is Lys-Pro-Val, the C-terminal alpha-MSH tripeptide. Evidence includes epithelial-cell and mouse colitis models; the prior SC oral and cream protocols were internal compilations rather than human trials.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention KPV or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.